COBENFY: payments to doctors
Payments that named COBENFY as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $13.8M
- Providers
- 24,179
- Transactions
- 108,898
- Average per transaction
- $127
The per-transaction average — $127 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 24,179 providers the average total is $571, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | $13,794,045 | 100.0% |
| Bristol Myers Squibb | $1,059 | 0.0% |